Long-term outcomes of 5-year survivors without recurrence after the complete resection of non-small cell lung cancer after lobectomy: a landmark analysis in consideration of competing risks

Houston KA, Mitchell KA, King J, White A, Ryan BM. Histologic lung cancer incidence rates and trends vary by race/ethnicity and residential county. J Thorac Oncol. 2018;13:497–509.

Article  PubMed  PubMed Central  Google Scholar 

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.

Article  PubMed  Google Scholar 

Rami-Porta R, Bolejack V, Giroux DJ, Chansky K, Crowley J, Lyons G, et al. TNM classification for lung cancer. J Thorac Oncol. 2015;10:990–1003.

Article  PubMed  Google Scholar 

Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109(1):120–9.

Article  CAS  PubMed  Google Scholar 

al-Kattan K, Sepsas E, Fountain SW, Townsend ER. Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg. 1997;12(3):380–4.

Article  CAS  PubMed  Google Scholar 

Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K, et al. Prognostic impact of intratumoral vascular invasion in non-small cell lung cancer patients. Thorax. 2010;65:1092–8.

Article  PubMed  Google Scholar 

Martini N, Rusch VW, Bains MS, Kris MG, Downey RJ, Flehinger BJ, et al. Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer. J Thorac Cardiovasc Surg. 1999;117:32–6.

Article  CAS  PubMed  Google Scholar 

Okada M, Nishio W, Sakamoto T, Harada H, Uchino K, Tsubota N, et al. Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma. J Thorac Cardiovasc Surg. 2003;126:558–62.

Article  PubMed  Google Scholar 

Maeda R, Yoshida J, Hishida T, Aokage K, Nishimura M, Nishiwaki Y, et al. Late recurrence of non-small cell lung cancer more than 5 years after complete resection: incidence and clinical implications in patient follow-up. Chest. 2010;138:145–50.

Article  PubMed  Google Scholar 

Shigefuku S, Shimada Y, Hagiwara M, Kakihana M, Kajiwara N, Ohira T, et al. Prognostic significance of ground-glass opacity components in 5-year survivors with resected lung adenocarcinoma. Ann Surg Oncol. 2021;28:148–56.

Article  PubMed  Google Scholar 

Sonoda D, Matsuura Y, Ichinose J, Nakao M, Ninomiya H, Mun M, et al. Ultra-late recurrence of non-small cell lung cancer over 10 years after curative resection. Cancer Manag Res. 2019;11:6765–74.

Article  PubMed  PubMed Central  Google Scholar 

Sekihara K, Hishida T, Yoshida J, Oki T, Omori T, Katsumata S, et al. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is “cured” from postoperative recurrence? Eur J Cardiothorac Surg. 2017;52(3):522–8.

Article  PubMed  Google Scholar 

Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K. Prognostic impact of a ground-glass opacity component in the clinical T classification of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2017;154(6):2102-2110.e1. https://doi.org/10.1016/j.jtcvs.2017.08.037.

Article  PubMed  Google Scholar 

Asamura H, Hishida T, Suzuki K, Koike T, Nakamura K, Kusumoto M, et al. Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. J Thorac Cardiovasc Surg. 2013;146:24–30.

Article  PubMed  Google Scholar 

Suzuki K, Koike T, Asakawa T, Kusumoto M, Asamura H, Nagai K, et al. A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol. 2011;6:751–6.

Article  PubMed  Google Scholar 

Ye T, Deng L, Wang S, Xiang J, Zhang Y, Hong Hu, et al. Lung adenocarcinomas manifesting as radiological part-solid nodules define a special clinical subtype. J Thorac Oncol. 2019;14:617–27.

Article  PubMed  Google Scholar 

Aokage K, Miyoshi T, Ishii G, Kusumoto M, Nomura S, Katsumata S, et al. Influence of ground-glass opacity and the corresponding pathological findings on survival in patients with clinical stage I non-small cell lung cancer. J Thorac Oncol. 2018;13:533–42.

Article  PubMed  Google Scholar 

Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, et al. Small adenocarcinoma of the lung: histologic characteristics and prognosis. Cancer. 1995;75:2844–52.

Article  CAS  PubMed  Google Scholar 

Okiror L, Harling L, Toufektzian L, King J, Routledge T, Karen H-P, et al. Prognostic factors including lymphovascular invasion on survival for resected non-small cell lung cancer. J Thorac Cardiovasc Surg. 2018;156:785–93.

Article  PubMed  Google Scholar 

Asamura H, Chansky K, Crowley J, Goldstraw P, Rusch WV, Vansteenkiste JF, et al. The International Association for the Study of lung cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol. 2015;10:1675–84.

Article  CAS  PubMed  Google Scholar 

Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606–12.

Article  CAS  PubMed  Google Scholar 

Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical, and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10:1243–60.

Article  PubMed  Google Scholar 

Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51.

Article  PubMed  Google Scholar 

Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–8.

Article  CAS  PubMed  Google Scholar 

Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, et al. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 year. N Engl J Med. 2017;377(19):1836–46.

Article  PubMed  PubMed Central  Google Scholar 

Klotz L, Vesprini D, Sethukavalan P, Jethava V, Zhang L, Jain S, et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol. 2015;33(3):272–7.

Article  PubMed  Google Scholar 

Schmidt-Kittler O, Ragg T, Daskalakis A, Granzow M, Ahr A, Blankenstein Thomas JF, et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA. 2003;100:7737–42.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Neophytou CM, Kyriakou TC, Papageorgis P. Mechanisms of metastatic tumor dormancy and implications for cancer therapy. Int J Mol Sci. 2019;20:6158.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif